Artículos por temáticas

Commentary: Progressive inflammation as a contributing factor to early development of Parkinson's disease.

Pradhan S, Andreasson K.

Exp Neurol. 2013 Mar;241:148-55. doi: 10.1016/j.expneurol.2012.12.008.

Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review.

Fagerlund K, Anderson LC, Gurvich O.

Am J Nurs. 2013 Jan;113(1):26-35; quiz 36. doi: 10.1097/01.NAJ.0000425744.76107.9f.

Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's disease.

Lieu CA, Chinta SJ, Rane A, Andersen JK.

PLoS One. 2013;8(1):e54200. doi: 10.1371/journal.pone.0054200.

Task-dependent interactions between dopamine D2 receptor polymorphisms and L-DOPA in patients with Parkinson's disease.

Kwak Y, Bohnen NI, Müller ML, Dayalu P, Burke DT, Seidler RD.

Behav Brain Res. 2013 May 15;245:128-36. doi: 10.1016/j.bbr.2013.02.016.

Stereopsis and extrastriate cortical atrophy in Parkinson's disease: a voxel-based morphometric study.

Koh SB, Suh SI, Kim SH, Kim JH.

Neuroreport. 2013 Mar 27;24(5):229-32. doi: 10.1097/WNR.0b013e32835edbc5.

Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease.

Biundo R, Weis L, Pilleri M, Facchini S, Formento-Dojot P, Vallelunga A, Antonini A.

J Neural Transm (Vienna). 2013 Apr;120(4):627-33. doi: 10.1007/s00702-013-1004-2.

Corticomotor excitability in drug-naive patients with Parkinson disease.

Derejko M, Rakowicz M, Antczak J, Inglot E, Niewiadomska M.

Neurol Neurochir Pol. 2013 Mar-Apr;47(2):109-15.

Ambulation and Parkinson disease.

Amano S, Roemmich RT, Skinner JW, Hass CJ.

Phys Med Rehabil Clin N Am. 2013 May;24(2):371-92. doi: 10.1016/j.pmr.2012.11.003. Review.

Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.

Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M.

Exp Neurol. 2013 Sep;247:45-58. doi: 10.1016/j.expneurol.2013.03.017.

Switching ability of over trained movements in a Parkinson's disease rat model.

Florio TM, Confalone G, Sciarra A, Sotgiu A, Alecci M.

Behav Brain Res. 2013 Aug 1;250:326-33. doi: 10.1016/j.bbr.2013.05.020.

Mortalin mutations are not a frequent cause of early-onset Parkinson disease.

Freimann K, Zschiedrich K, Brüggemann N, Grünewald A, Pawlack H, Hagenah J, Lohmann K, Klein C, Westenberger A.

Neurobiol Aging. 2013 Nov;34(11):2694.e19-20. doi: 10.1016/j.neurobiolaging.2013.05.021.

Quality of life and depressive symptoms in Parkinson's disease after subthalamic deep brain stimulation: a 2-year follow-up study.

Tykocki T, Szalecki K, Koziara H, Nauman P, Mandat T.

Turk Neurosurg. 2013;23(3):379-84. doi: 10.5137/1019-5149.JTN.7184-12.1.

[Freezing and gait disorders in Parkinson's disease].

Gonçalves G, Pereira J.

Rev Med Chil. 2013 Jun;141(6):758-64. doi: 10.4067/S0034-98872013000600010. Review. Spanish.

Sleep and impulsivity in Parkinson's disease.

Scullin MK, Sollinger AB, Land J, Wood-Siverio C, Zanders L, Lee R, Freeman A, Goldstein FC, Bliwise DL, Factor SA.

Parkinsonism Relat Disord. 2013 Nov;19(11):991-4. doi: 10.1016/j.parkreldis.2013.06.018.

Granulocyte-colony stimulating factor improves Parkinson's disease associated with co-morbid depression: an experimental exploratory study.

Prakash A, Chopra K, Medhi B.

Indian J Pharmacol. 2013 Nov-Dec;45(6):612-5. doi: 10.4103/0253-7613.121374.